Votre recherche pour: 1-Naphthyl+phosphate+disodium+salt
124 les résultats ont été trouvés
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/fr/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
Upstream Gene Therapy Products & Solutions in Bioprocessing
/cms/nl/bioprocessing_gene_therapy_upstream_processing
Upstream Gene Therapy Products & Solutions in Bioprocessing Achieve optimal generation of gene therapy vectors with our non-viral transfection and viral transduction products. Avantor® can provide culture systems that support processes development...
ls ge29064277 20131210235846
/m-be.vwr.com/fr_BE/images/ls_ge29064277_20131210235846.pdf
imagination at work Application note 29-0642-77 AB Chromatography systems Purification of an N-terminal histidine-tagged protein using ÄKTA™ start ÄKTA start eliminates the hassles of manual protein purification handling such as loading large samp...
Final fill for cell therapy
/cms/fr/bioprocessing_cell_therapy_final_fill
Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...
Final fill for cell therapy
/cms/nl/bioprocessing_cell_therapy_final_fill
Final fill for cell therapy The cell therapy drug product is configured in different ways depending on the required delivery of the cells/tissues. For example delivery of chondrocytes for cartilage repair is administered by an injection. Expanded ...
PEIpro Poster
/m-be.vwr.com/nl_BE/images/Poster-PEIpro-Virus-PepTalk2018.pdf
PEIpro Poster Reproducibility & Scalability Excellent lot-to-lot protein yield reproducibility using PEIpro®. Suspension HEK-293 cells were seeded at 1×106 cells/mL in serum-free medium and transfected with PEIpro® following the standard protocol....
ls ge29064277 20131210235846
/m-be.vwr.com/nl_BE/images/ls_ge29064277_20131210235846.pdf
imagination at work Application note 29-0642-77 AB Chromatography systems Purification of an N-terminal histidine-tagged protein using ÄKTA™ start ÄKTA start eliminates the hassles of manual protein purification handling such as loading large samp...
PEIpro Poster
/m-be.vwr.com/fr_BE/images/Poster-PEIpro-Virus-PepTalk2018.pdf
PEIpro Poster Reproducibility & Scalability Excellent lot-to-lot protein yield reproducibility using PEIpro®. Suspension HEK-293 cells were seeded at 1×106 cells/mL in serum-free medium and transfected with PEIpro® following the standard protocol....
Downstream purification for recombinant proteins
/cms/fr/bioprocessing_recombinant_proteins_downstream_purification
Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...
Downstream purification for recombinant proteins
/cms/nl/bioprocessing_recombinant_proteins_downstream_purification
Downstream purification for recombinant proteins With more than 30 years of chromatography experience developed products and services we have every solution to meet your needs. Our J.T.Baker® brand BAKERBOND™ chromatography resins have been used s...
Aurora Manufacturing Facility
/cms/nl/7348B7481E96478C9B0ABCBEFAE89EDB
Aurora Manufacturing Facility Core Capabilities Supply of excipients down-packed in controlled and segregated environments to meet analytical and biological requirements Custom finished goods packaging configurations including OEM packaging and la...
Final fill for mAbs
/cms/nl/bioprocessing_mabs_final_fill
Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...
Final fill for vaccines
/cms/nl/bioprocessing_vaccines_final_fill
Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...
Final fill for mAbs
/cms/fr/bioprocessing_mabs_final_fill
Final fill for mAbs Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO Cla...
Upstream processing for cell therapy
/cms/nl/bioprocessing_cell_therapy_upstream_processing
Upstream processing for cell therapy Compared to production volumes associated with other biologics (e.g. mAbs: 2000L to 10000L) cell therapy production volumes are more commonly between 1L to 10L. Even the quality parameters are different. Instea...
Final fill for vaccines
/cms/fr/bioprocessing_vaccines_final_fill
Final fill for vaccines Progressing from the drug substance to the final injectable drug product requires final packaging vials and stoppers that meet a number of quality requirements. To meet these requirements products must be prepared in an ISO...
49 - 64 of 124